Latest On Baxter International Inc (BAX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-08-30 05:41 EST | Dividend | A dividend of $0.29 has been announced on Jul 16, 2024. It will be paid Oct 1, 2024 with an ex-dividend date of Aug 30, 2024. | Neutral |  |
| 2024-05-31 05:41 EST | Dividend | A dividend of $0.29 has been announced on May 7, 2024. It will be paid Jul 1, 2024 with an ex-dividend date of May 31, 2024. | Neutral | |
| 2024-02-29 04:41 EST | Dividend | A dividend of $0.29 has been announced on Feb 12, 2024. It will be paid Apr 1, 2024 with an ex-dividend date of Feb 29, 2024. | Neutral | |
| 2023-11-30 04:41 EST | Dividend | A dividend of $0.29 has been announced on Nov 14, 2023. It will be paid Jan 2, 2024 with an ex-dividend date of Nov 30, 2023. | Neutral | |
| 2023-08-31 05:41 EST | Dividend | A dividend of $0.29 has been announced on Jul 18, 2023. It will be paid Oct 2, 2023 with an ex-dividend date of Aug 31, 2023. | Neutral | |
About Baxter International Inc (BAX):
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic in read more...jectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
General
- Name Baxter International Inc
- Symbol BAX
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 50,000
- Last Split Factor1841:1000
- Last Split Date2015-07-01
- Fiscal Year EndDecember
- IPO Date1981-10-27
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://www.baxter.com
Valuation
- Trailing PE 37.49
- Forward PE 23.53
- Price/Sales (Trailing 12 Mt.) 3.53
- Price/Book (Most Recent Quarter) 4.63
- Enterprise Value Revenue 3.71
- Enterprise Value EBITDA 19.1
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $3.40
- Next Year EPS Estimate $3.98
- Next Quarter EPS Estimate $0.72
- Profit Margin 9%
- Operating Margin 16%
- Return on Assets 6%
- Return on Equity 13%
- Revenue 11.67 billion
- Earnings Per Share $2.13
- Revenue Per Share $22.93
- Gross Profit 4.73 billion
- Quarterly Earnings Growth 4.7%
ESG Rating
Highlights
- Market Capitalization 40.34 billion
- EBITDA 2.7 billion
- PE Ratio 7.82
- PEG Ratio 2.32
- Analyst Target Price $92.18
- Book Value Per Share $17.21
Share Statistics
- Shares Outstanding 505.1 million
- Shares Float 504.14 million
- % Held by Insiders 14%
- % Held by Institutions 88.73%
- Shares Short 8.18 million
- Shares Short Prior Month 7.14 million
- Short Ratio 2.65
- Short % of Float 2%
- Short % of Shares Outstanding 2%
Technicals
- Beta 0.66
- 52 Week High $94.06
- 52 Week Low $68.87
- 50 Day Moving Average 77.82
- 200 Day Moving Average 79.44
Dividends
- Forward Annual Dividend Rate $0.98
- Forward Annual Dividend Yield 1.23%
- Payout Ratio 32%
- Dividend Date 2021-04-01
- ExDividend Date 2021-02-25
- Dividend Per Share $0.96
- Dividend Yield 3.02%
Baxter International Inc (BAX) Dividend Calendar:
Baxter International Inc pays an annual dividend of $0.98 per share, with a dividend yield of 3.02%.
BAX's last dividend payment was made to shareholders on April 1, 2021.
Baxter International Inc pays out 32% of its earnings out as a dividend.
Baxter International Inc (BAX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Baxter International Inc (BAX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Baxter International Inc (BAX) Chart:
Baxter International Inc (BAX) News:
Below you will find a list of latest news for Baxter International Inc (BAX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Baxter International Inc (BAX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest BAX Trades:
Baxter International Inc (BAX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-06 | 8-K (Current report) | |
| 2020-11-04 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-29 | 8-K (Current report) | |
| 2020-10-29 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-10-29 | 8-K (Current report) | |
| 2020-10-08 | 8-K (Current report) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-28 | 8-K (Current report) | |
| 2020-09-25 | 8-K (Current report) | |
| 2020-09-15 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-15 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 3 (Initial statement of beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-24 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-24 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-30 | 8-K (Current report) | |
| 2020-07-30 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-06-30 | 11-K (Annual report of employee stock purchase, savings and similar plans) | |
Baxter International Inc (BAX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Baxter International Inc (BAX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 14%
Institutional Ownership: 8873%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-11-02 | Sean Martin | SVP and General Counsel | Sell | 10,393.00 | 79.22 | 823,333.46 | 39,640.00 | |
| 2020-11-02 | Sean Martin | SVP and General Counsel | Sell | 36,608.00 | 78.52 | 2,874,460.16 | 50,033.00 | |
| 2020-11-02 | Sean Martin | SVP and General Counsel | Buy | 47,001.00 | 50.77 | 2,386,240.77 | 86,641.00 | |
| 2020-09-14 | JOHN D FORSYTH | Director | Sell | 310.00 | 83.59 | 25,912.90 | 33,969.00 | |
| 2020-09-14 | JOHN D FORSYTH | Director | Buy | 310.00 | 31.26 | 9,690.60 | 34,279.00 | |
| 2020-09-01 | James W Borzi | SVP, Global Supply Chain | Buy | 12,000.00 | 12,000.00 | | ||
| 2020-08-03 | JAMES R III GAVIN | Director | Sell | 3,351.00 | 86.91 | 291,235.41 | 39,508.00 | |
| 2020-08-03 | JAMES R III GAVIN | Director | Sell | 11,548.00 | 86.26 | 996,130.48 | 42,859.00 | |
| 2020-08-03 | JAMES R III GAVIN | Director | Buy | 4,110.00 | 39.83 | 163,701.30 | 43,618.00 | |
| 2020-08-03 | JAMES R III GAVIN | Director | Buy | 10,789.00 | 37.50 | 404,587.50 | 54,407.00 | |
| 2020-06-19 | Giuseppe Accogli | SVP, President, Americas | Buy | 62,388.00 | 50.77 | 3,167,438.76 | 138,861.00 | |
| 2020-06-19 | Giuseppe Accogli | SVP, President, Americas | Sell | 72,341.00 | 85.00 | 6,148,985.00 | 66,520.00 | |
| 2020-06-19 | Giuseppe Accogli | SVP, President, Americas | Buy | 8,334.00 | 46.18 | 384,864.12 | 76,473.00 | |
| 2020-06-15 | JOHN D FORSYTH | Director | Sell | 1,500.00 | 82.95 | 124,425.00 | 33,898.00 | |
| 2020-06-15 | JOHN D FORSYTH | Director | Buy | 1,500.00 | 31.26 | 46,890.00 | 35,398.00 | |
| 2020-06-08 | Cristiano Franzi | SVP, President, EMEA | Sell | 22,700.00 | 87.96 | 1,996,692.00 | 39,088.00 | |
| 2020-06-08 | Cristiano Franzi | SVP, President, EMEA | Sell | 23,900.00 | 87.33 | 2,087,187.00 | 61,788.00 | |
| 2020-06-08 | Cristiano Franzi | SVP, President, EMEA | Buy | 46,600.00 | 62.23 | 2,899,918.00 | 85,688.00 | |
| 2020-06-03 | Andrew Frye | SVP, President, APAC | Sell | 3,742.00 | 91.00 | 340,522.00 | 16,216.00 | |
| 2020-05-05 | Stephen N. Oesterle | Director | Buy | 2,197.00 | 11,133.00 | |